愛柯迪(600933.SH):副總經理吳飛減持完畢 累計減持5萬股
格隆匯7月6日丨愛柯迪(600933.SH)公佈,本次減持計劃實施前,副總經理吳飛持有公司股份20萬股,佔公司總股本的0.0233%,其股份來源為公司實施股權激勵計劃獲得的股份,第一個解除限售期解鎖數量8萬股已於2019年9月18日解除限售並上市流通。
公司於2020年7月6日收到吳飛送達的《關於減持愛柯迪股份有限公司股份結果的告知函》,吳飛通過集中競價交易方式累計減持公司股份5萬股,佔公司總股本的0.0058%,截止本公告日,吳飛減持計劃已實施完畢。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.